DDrare: Database of Drug Development for Rare Diseases

Other: rhythmic auditory stimulation (ras) (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
13	Multiple sclerosis/Neuromyelitis optica	1

6. Parkinson disease [ 2,123 clinical trials, 2,046 drugs, (DrugBank: 324 drugs), 183 drug target genes, 198 drug target pathways]

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,123 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03316365 (ClinicalTrials.gov)	August 2009	16/10/2017	Long-term Training Effects of Rhythmic Auditory Stimulation on Gait in Patients With Parkinson's Disease	Long-term Training Effects of Rhythmic Auditory Stimulation on Gait in Patients With Parkinson's Disease	Continuous Rhythmic Auditory Stimulation;Intermittent Rhythmic Auditory Stimulation	Other: Rhythmic Auditory Stimulation (RAS)	University of Toronto	Poudre Valley Health System Fort Collins CO;Colorado State University	Completed	18 Years	N/A	All	60	N/A	NULL

13. Multiple sclerosis/Neuromyelitis optica [ 3,050 clinical trials, 2,147 drugs, (DrugBank: 348 drugs), 244 drug target genes, 228 drug target pathways]

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 3,050 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02065284 (ClinicalTrials.gov)	February 2014	13/2/2014	Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis	Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.	Multiple Sclerosis;Ambulation Difficulty	Other: Rhythmic Auditory Stimulation (RAS)	The Cleveland Clinic	The Kelvin and Eleanor Smith Foundation;The Kelvin and Eleanor Smith Foundation	Completed	18 Years	N/A	Both	32	N/A	United States